Status:
RECRUITING
Laser Treatment of Reticular Leg Veins Vs. Sclerotherapy
Lead Sponsor:
Derzhavin Tambov State University
Conditions:
Reticular Leg Veins
Eligibility:
FEMALE
18-75 years
Phase:
NA
Brief Summary
Treatment of reticular veins with a 1064 nm long-pulsed Nd:YAG laser and combination of a 1064 nm Nd:YAG long pulse laser and sclerotherapy should be no less effective than sclerotherapy alone, and ha...
Detailed Description
Reticular leg veins are mostly an aesthetic problem. Sclerotherapy is considered the gold standard for treatment them. However, this method has a high frequency of long persistent hyperpigmentation wh...
Eligibility Criteria
Inclusion
- women over 18
- reticular veins
- signed informed consent to participate in the study
Exclusion
- diabetes mellitus
- pregnancy or lactation
- malignant neoplasms
- inability or unwillingness of the patient to wear compression stockings
- hypersensitivity to the polidocanol, cold, sunlight
- concomitant diseases: bronchial asthma, severe liver and kidney disease, acute thrombosis and thrombophlebitis, infection of the skin and/or soft tissues, infectious diseases, arteriosclerosis, diabetic angiopathy, heart defects requiring surgery, fever, toxic hyperthyroidism, obesity, tuberculosis, sepsis, violation of the cellular composition of the blood, all diseases requiring bed rest, heart disease with decompensation phenomena,
- known hereditary thrombophilia.
- period after treatment of alcoholism
- reception of oral contraceptives
- sedentary lifestyle
Key Trial Info
Start Date :
October 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 9 2025
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT06175754
Start Date
October 9 2023
End Date
December 9 2025
Last Update
February 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bukina Oksana Vasilyevna
Tambov, Russia, 392002